• + Chinese   + English
  • Home page About Granlen | News and Events | Products | Infrastructure | Culture & Career | Contact Us |

Fluoro-modified nucleosides
Halo-nucleosides
2’-Modified nucleosides
3’-Modified nucleosides
4’-Modified nucleosides
5’-Modified nucleosides
3’-Deoxy nucleosides
5’-Deoxy nucleosides
2’,3’-Dideoxy nucleosides
Didehydro-nucleosides
Azido-nucleosides
Amino nucleosides
Thio-nucleosides
Iso-cytidine derivatives
Iso-guanosine derivatives
Arabino-nucleosides
Xylo-nucleosides
2-Modified purine nucleosides
6-Modified purine nucleosides
6-De-aminopurine nucleosides
8-Modified purine nucleosides
7-Deaza-purine nucleosides
8-Aza-7-deaza-purine nucleosides
6-Aza-uridines
5,6-Dihydro-uridines
3-Deazauridines
4-Deoxypyrimidine nucleosides
5-Modified pyrimidine nucleosides
6-Modified pyrimidine nucleosides
Anhydro-nucleosides
Pyridine nucleosides
Bi-/Tricyclic nucleosides
Morpholino-nucleosides
N-Methylated/alkylated nucleosides
Naturally modified ribo-nucleosides
C-nucleosides
Acyclic nucleosides
LNA-related nucleosides
Phosphorus-containing nucleotides
Alpha-Nucleosides
L-Nucleosides
Indole nucleosides
Protected nucleosides with NH2/OH open
2-Deoxy uridines
Other modified nucleosides
 
+86-371-6711 0368

Nucleoside Derivatives

Home page  >  Products  >  Nucleoside Derivatives  >  2’-Modified nucleosides

GL103019

Catalog   No.

GL103019

Name

Sofosbuvir

Synonyms


Formula

C22H29FN3O9P

FW

529.45

CAS No.

1190307-88-0

Purity

≥ 95%

Property


Package  

Packed   as desired

Classification

Nucleoside   Derivatives – Fluoro-modified nucleosides; 2’-Modified nucleosids;   5’-Modified nucleosides; Phosphorus-containing nucleosides; Drugs and   Inhibitors

Notes:  

HCV drug  Sofosbuvir


About Granlen  |   News and Events  |   Products  |   Infrastructure  |   Culture & Career  |   Contact Us  |  

© 1998 - 2020 Granlen Inc. All Rights Reserved   豫ICP备19022032号-1